Zhaokai Zhou

Central South University — China

Medicine · Health Sciences

17h-index1.1kcitations91works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ferroptosis and cancer prognosis(13), Immune cells in cancer(11), Immunotherapy and Immune Responses(8), CAR-T cell therapy research(8), Cancer Immunotherapy and Biomarkers(6)

Publications91 total

Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions
Biomarker Research·2026Open Access
Inhibitory effect of blestriarene C on triple-negative breast cancer: inducing ferroptosis and mitophagy via SESN2/AKT/FOXO4 axis
Chinese Medical Journal·2026Open Access
Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions
Interdisciplinary medicine·2026Open Access
Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects
Canadian Journal of Urology·2026
The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy
Cancer Communications·2026Open Access
Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions (1/2026)
Interdisciplinary medicine·2026Open Access
Cancer-Associated Fibroblasts in Prostate Cancer: Unraveling Mechanisms and Therapeutic Implications
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics·2025Open Access
Progression on Mechanism and Therapeutic Implications of Neddylation in Lung Cancer
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics·2025Open Access
Novel common target genes for breast cancer and colorectal cancer: a Mendelian randomization and spatial transcriptomics study
Discover Oncology·2025Open Access
Deep multimodal fusion of patho-radiomic and clinical data for enhanced survival prediction for colorectal cancer patients
npj Digital Medicine·2025· 1 citedOpen Access
Co-targeting ferroptosis and immune evasion through small molecules in breast cancer
Journal of Translational Internal Medicine·2025Open Access
Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives
Molecular Cancer·2025· 6 citedOpen Access
Gene-interaction perturbation network analysis identifies distinct subtypes and actionable targets for aggressive thyroid cancer: an integrative multi-omics and machine learning approach for precise medicine
2025Open Access
Therapeutic potential of glycyrrhizin in nervous system diseases
Chinese Medical Journal·2025Open Access
Glucagon-like peptide-1 receptor agonists and sarcopenia-related markers in diabetes: A systematic review and meta-analysis
Clinical Nutrition·2025· 2 cited
Characterization of cancer-related fibroblasts in bladder cancer and construction of CAFs-based bladder cancer classification: insights from single-cell and multi-omics analysis
Frontiers in Immunology·2025· 1 citedOpen Access
Targeting <scp>ARPC1B</scp> <sup>+</sup> Cancer Stem Cells to Sensitise Pancreatic Cancer to Gemcitabine Treatment
Cell Proliferation·2025· 1 citedOpen Access
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Molecular Cancer·2025· 22 citedOpen Access
A comprehensive review of ethnopharmacology, phytochemistry, pharmacological effects, and quality control of Bletilla striata
Journal of Ethnopharmacology·2025· 1 cited
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma
Journal for ImmunoTherapy of Cancer·2025· 47 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Siyuan Weng(20), Xinwei Han(19), Zaoqu Liu(16), Yuyuan Zhang(16), Yuhao Ba(14), Anning Zuo(11), Quan Cheng(9), Ge Zhang(9), Yudi Xu(9), Peng Luo(7), Shuai Yang(7), Qin Dang(6), Shutong Liu(6), Shutong Liu(6), Chuhan Zhang(6), Yukang Chen(6), Zaoqu Liu(6), Qiong Lu(6), Jinxiang Lv(5), Yuqing Ren(5)